Announcements

5 March 2026
Pharmaceutics Sponsoring the 13th International Dendrimer Symposium (IDS13), 30 September–2 October 2026, Stockholm, Sweden


Pharmaceutics
(ISSN: 1999-4923) is proud to announce its role as a sponsor for the 13th International Dendrimer Symposium (IDS13). This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in critical industry discussions with the public.

Time: 30 September–2 October 2026
Place: Stockholm, Sweden
Website: https://ids13.se/
Contact: conference-ids13@kth.se
Early-Bird Registration Deadline: 31 March 2026

The IDS13 scientific program is designed to showcase the diversity of dendritic polymers. Seven thematic areas, spanning synthesis, structure, therapeutics, antimicrobial systems, photo-responsive materials, commercialization, and emerging horizons, will ensure comprehensive coverage across the entire dendritic spectrum.

World-Class Plenary and Invited Speakers

IDS13 boasts an internationally renowned lineup of confirmed speakers—pioneers and leading experts in dendrimer chemistry, nanomedicine, supramolecular science, regenerative medicine, and functional materials—hailing from the USA, France, Japan, China, Spain, Norway, Singapore, Poland, the Netherlands, Portugal, Italy, Taiwan, Turkey, Denmark, and more. Highlights include plenary lectures from the following:

  • Prof. D. A. Tomalia (USA, Dendrimer Chemistry);
  • Prof. V. Percec (USA, Supramolecules);
  • Prof. J-P Majoral (France, Dendrimer Chemistry);
  • Prof. K. Rangaramanujam (USA, Nanomedicine).

And many other distinguished scientists in the field (full speaker list available on the official website).

About the Media Partner: Pharmaceutics

Pharmaceutics (ISSN: 1999-4923; IF: 5.5) is a leading international peer-reviewed open access journal published by MDPI, dedicated to all aspects of pharmaceutical sciences, including drug delivery systems, nanomedicine, pharmaceutical materials, and biopharmaceutics. As the media partner for IDS13, Pharmaceutics will feature symposium highlights, research spotlights, and author opportunities for attendees, connecting the dendrimer research community with the broader pharmaceutical science field.

Dendrimers stand at the forefront of next-generation nanomaterials, with transformative potential for precision drug delivery, cancer immunotherapy, regenerative medicine, diagnostics, and sustainable high-performance materials. IDS13 is your opportunity to be part of this global conversation, share your research, and collaborate with the brightest minds in the field to advance dendritic science for the benefit of medicine, materials, and society.

We look forward to welcoming you in Stockholm in September 2026!

4 March 2026
MDPI’s 2025 Best Paper Awards—Award-Winning Papers Announced


MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

 

28 February 2026
MDPI INSIGHTS: The CEO’s Letter #32 - MDPI China and Thailand, China Science Daily, 1,000 Partnerships, R2R

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from China: Year-End-Celebrations and Open Access Publishing

In February, I had the pleasure of joining over a thousand colleagues from our Tongzhou and Haidian offices at their end-of-year annual celebration in Beijing.

Spending time with our teams in China is also a powerful reminder of the scale and complexity of MDPI as a global organization. Our colleagues in Beijing, Wuhan, and across the country play a significant role in our day-to-day operations and long-term development. I’m grateful for the hospitality, collaboration, and commitment shown by our managers and teams in China, alongside colleagues worldwide, who have helped steadily build MDPI, brick by brick, over the years.

Below are some data on Open Access (OA) publishing in China and our collaboration in this important research market.

Open Access Publishing in China

China has been the world’s leading country in research and review article publication volume since 2019, exceeding one million publications in 2025. Over the past five years, the gap between China and the second-ranked country, the United States, has continued to widen.

In 2025:

  • 47% of China’s research output was published Open Access
  • Of those OA publications, 76% were Gold Open Access (approximately 382,930 articles)
  • The overall OA distribution remained stable compared with 2024, with Gold OA increasing by 1%

Over the past five years (2021–2025):

  • China published 4,398,050 research and review articles
  • Approximately 48% of this output was OA

According to Dimensions, when comparing the top 20 countries by publication volume (2021–2025):

  • China ranks 1st worldwide in publication volume
  • China ranks 9th in citation performance within this group (for comparison, the US ranks 2nd in publication volume and 10th in citation ranking)
  • Average citations per article: 12.51

Among the top 10 universities globally by publication volume, six are Chinese institutions, alongside Harvard University (USA), the University of São Paulo (Brazil), the University of Toronto (Canada), and the University of Oxford (UK).

MDPI and China

China is an important and long-standing part of MDPI’s global publishing ecosystem:

  • In 2025, MDPI was the largest fully Open Access publisher in China
  • MDPI published 22% of China’s Gold Open Access output (82,133 papers)
  • We received 290,999 submissions from China-affiliated authors and published 82,133 articles
  • There are 8,500+ active Editorial Board Members based in China
    • 64% (5,438) have an H-index above 26
  • MDPI works with:
    • 117 Editors-in-Chief
    • 103 Section Editors-in-Chief
  • 71 China-based institutions currently hold IOAP agreements with MDPI, seven of which rank among the top 10 Chinese institutions by publication volume

China's scale in research output means that the publishing platforms chosen by Chinese scholars will continue to influence the direction of scholarly publishing. At the same time, MDPI’s strength comes from its international collaboration, with colleagues, editors, reviewers, and authors working together across regions and disciplines.

Thank you to all our colleagues in China, and around the world, who support MDPI’s publishing activities across departments and help advance open access research every day.

Impactful Research

“Progress in open science is built through trust, dialogue, and relationships”

Behind the Scenes: A Conversation with China Science Daily

During my trip to Beijing, I also had the opportunity to visit China Science Daily and take part in an interview and broader exchange with their team in Beijing. Visits like this matter because progress in open science is built not only through platforms and infrastructure, but also through trust, dialogue, and relationships across research communities and regions.

China Science Daily: History Museum

As part of the visit, I was given a tour of their History Museum, which offers a thorough perspective on the evolution of China’s first science and technology newspaper, established in 1959. The exhibition highlights how the organization developed into a trusted institution connecting research with the public and policymakers. It was a helpful reminder that at the core of publishing is stewardship, credibility, and long-term public engagement with science.

An Open Exchange on Open Science

During the visit, I met with Dr. Zhao Yan, Editor-in-Chief of ScienceNet. We had an open and engaging conversation about MDPI’s role in Open Access, the evolution of open science globally, and the potential for more collaboration going forward. He especially appreciated the candid and personal nature of our exchange, noting that this kind of dialogue feels important in a landscape where trust and transparency matter.

Interview on Open Access

I also participated in an interview with Ms. Yan Jie, from the Online Media Center and Editor-in-Chief of ScienceNet, China Science Daily. Our discussion covered the growth of Open Access over the past 30 years, MDPI’s mission and values, academic integrity, collaboration with the Chinese research community, and MDPI’s own 30th anniversary milestone. It was a great opportunity to reflect on how open science has matured, and where shared responsibility across publishers, institutions, and researchers continues to matter most.

“Progress in open science is built by more than scale and infrastructure”

I’m sharing a few photos from the visit as a glimpse behind the scenes. The full interview will be published by China Science Daily in due course, and I look forward to sharing it when it is available.

More broadly, visits like this reinforce something I’ve always believed in: progress in open science is built not only through scale and infrastructure, but also through continued dialogue, mutual respect, collaboration, and a willingness to listen across regions and perspectives. That remains central to our work, especially as MDPI reflects on 30 years of publishing, built together.

Inside MDPI

Bangkok Visit: Growth, Partnership, and Local Impact

In February, I also had the opportunity to visit our Bangkok office for the second time in two years to support their local meetings and deliver a training session on how we present MDPI at a corporate level.

It’s easy to spend time with our colleagues in Thailand. From Editorial and Production to Conferences, Marketing, Design, and our Regional Journal Relations Specialist (RJRS), the team continues to grow in scale and professionalism. I’d also like to recognize our local management and admin teams, who have been steadily expanding our office and supporting more than 500 colleagues on the ground.

Academic Partnerships

During the visit, we met with the Engineering Department at King Mongkut’s Institute of Technology Ladkrabang (KMITL). Our discussion focused on the recent MDPI developments, Institutional Open Access Program (IOAP) opportunities, Author Publishing Workshops (APW), and the potential use of JAMS to support their institutional journal.

“MDPI is the third-largest OA publisher in Thailand”

We also shared insights into the growth of Open Access (OA) in Thailand and KMITL’s own publishing trends. These conversations matter because institutions are looking for sustainable ways to support their researchers. Our IOAP agreements are one simple example of how we can provide value in this area while maintaining accessibility for authors.

Thailand and MDPI: 2025 Snapshot

Our Bangkok office, officially launched in 2022, has been growing to support over 500 staff members while continuing to expand its engagement in scholar visits, workshops, and conference collaborations. As at 2025, Thailand submissions to MDPI have increased about 21% and publications by about 25%, maintaining a rejection rate close to the company average. MDPI is the third-largest OA publisher in Thailand, publishing 15% of all Gold OA output in 2025.

Representing MDPI Externally

During the visit, I delivered a training session on how we present MDPI at external events.

This session covered topics related to:

  • Our aim and guiding principles
  • High-level company milestones and Indexing facts and figures
  • Industry partnerships and collaborations
  • Market trends in OA and subscription publishing
  • Country-specific publishing data and collaborations with MDPI
  • Insights from our Voice of Community report

I find that while many colleagues are very familiar with the specific journal for which they have responsibility, fewer have visibility into the broader MDPI ecosystem and the company’s global positioning. These sessions help build alignment, confidence, and consistency in how we represent the company.

What stands out most is that MDPI’s growth is not abstract: it’s visible in the people, the partnerships, and the professionalism developing across our offices.

Coming Together for Science

1,000 Institutional Partners: A Milestone Built on Trust

This month, we reached an important milestone: more than 1,000 institutions worldwide are now part of MDPI’s Institutional Open Access Program (IOAP). On paper, that is a number. In practice, it represents trust.

This milestone symbolizes thousands of conversations with libraries and institutions. It stands for negotiations, renewals, consortium expansions, and, most importantly, relationships built over time. It reflects the work of colleagues across publishing, institutional partnerships, marketing, editorial, finance, and many other teams who contribute to making these agreements operational.

In 2025 alone, more than 61,300 research articles benefited from article processing charge (APC) discounts through IOAP agreements. Tens of thousands of authors were able to publish through a simplified and structured process. At the same time, institutional administrators gained clearer oversight and streamlined workflows.

Why IOAP Matters

When we launched IOAP, the objective was straightforward: to reduce barriers for researchers while supporting institutions in navigating the evolving OA landscape. Over the past decade, the research ecosystem has changed. Funder mandates, national policies, and Plan S–aligned requirements have accelerated the transition to OA.

Institutions need publishing partners who provide transparency, scalability, and operational efficiency. IOAP was designed to support that reality.

For colleagues who would like to better understand the program, this blog-post overview of MDPI’s IOAP provides additional context, including common questions around the transition to OA and how our institutional partnerships are structured.

“Institutions need publishing partners who provide transparency, scalability, and operational efficiency”

Recent Examples

Our agreements continue to evolve across regions:

These examples show that institutions seek structured, predictable models that support their researchers at scale.

Looking Ahead

Crossing the threshold of 1,000 partners tells us that institutions see MDPI not just as a publisher but as a reliable operational partner in advancing open science. This milestone is not a finish line. It is a reminder that the work continues.

Thank you to the entire IOAP team and to all colleagues who contributed to reaching this achievement.

P.S. You can read about this milestone across industry outlets, including STM Publishing News, ALPSP, Research Information, EurekAlert, Brightsurf, among others. You can also read about the coverage in Poland (e.g., media-room, bomega) Korea (newstap), and Romania (EduLike).

Closing Thoughts

Reflections from the Researcher to Reader Conference

During 24–25 February, I attended the 2026 Researcher to Reader Conference in London, UK. Leaders from across scholarly publishing, research infrastructure, libraries, and technology gathered to discuss AI and research integrity, peer review reform, metadata and infrastructure, community engagement, open research policy, and the evolving role of publishers in a rapidly shifting ecosystem.

The conversations were open and honest, and at times uncomfortable – exactly what we need at times. Below are a few reflections that stayed with me.

The Battle for Knowledge: What Becomes Accepted as ‘True’?

One recurring theme was not whether science evolves but whether our infrastructure is resilient enough to sustain trust at scale. Science does not promise certainty: it promises process. As publishing systems grow more complex and become more technologically mediated, the question is how intentionally we design, monitor, and strengthen that process.

Peer Review: Speed, Credentials, and Structural Loops

Researchers consistently call for faster peer review. At the same time, reviewer credentials are often tied to publication records. This creates a structural loop. Publishing history opens reviewing opportunities, reviewing strengthens credentials, and those without early access remain outside the cycle.

There is a need for us to reflect on how opportunity circulates within our systems: we should ask how we create more inclusive pathways for researchers globally to participate in peer review.

Community Engagement Workshop

One of the highlights of R2R was the workshop format, whereby small groups met repeatedly over two days and moved from ideas to tangible strategies.

I joined the Community Engagement workshop led by Lou Peck (CEO at The International Bunch) and Godwyns Onwuchekwa (Principal Consultant at Global Tapestry Consulting). We explored two deceptively simple questions: What is a community? and What does engagement truly mean?

“Engagement requires shared design and shared responsibility”

Too often, organizations equate communication with engagement. The framework discussed mapped a maturity spectrum – from enablement (broadcasting, informing and consulting) to true engagement (collaborating and co-creating).

It was a useful reminder of the fact that if we want trust and loyalty, engagement must go beyond announcements and surveys. It requires shared design and shared responsibility.

AI: Democratization or Digital Colonialism?

I especially enjoyed the thought-provoking presentation from Nikesh Gosalia (Chief Partnership Officer at Cactus Communications), which highlighted an uncomfortable reality:

  • 93% of AI-generated content is in English
  • Approximately 2% is in French
  • Approximately 2% is in German
  • More than 7,000 languages are represented in less than 5% of the content within large AI systems

The implications are profound. Is AI democratizing access to scholarly publishing (making it easier for researchers everywhere to participate in global knowledge production)? Or are we encoding colonialism at scale (entrenching linguistic and structural hierarchies, and making it harder for voices from the Global South to be heard)?

AI is already reshaping how research is created, reviewed, discovered, and shared. Its potential is enormous. But its impact depends not only on capability, but on governance, design, and intentionality. Publishers, funders, and researchers all share responsibility in shaping how these systems evolve.

Ethicality in practice (Lightening Talk)

It was also great to have our colleague Dr Miloš Čučulović (Head of Technology Innovation at MDPI) present MDPI’s Ethicality platform during a lightning talk.

“Technology alone is not the answer”

Ethicality embeds AI-driven checks directly into the submission workflow, supporting editors proactively rather than reacting after publication. As we scale, tools like this help balance trust, efficiency, and research integrity.

This goes back into the underlying theme of the conference that technology alone is not the answer. However, technology embedded thoughtfully within clear governance frameworks can strengthen confidence in the editorial process.

Final thought

The question is no longer whether technology will transform research infrastructure: it is already doing so. The real question is what role each of us will play in shaping that transformation deliberately, with structural maturity, inclusive governance, and engagement that moves from informing to co-creating.

Science needs to evolve, responsibly. And that responsibility extends not only to what we publish, but also to how the systems behind publication are designed. Some important topics to continue reflecting on both internally and within our broader community.

Stefan Tochev
Chief Executive Officer
MDPI AG

26 February 2026
Pharmaceutics Sponsoring the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 23–26 March 2026, Prague, Czech Republic


Pharmaceutics (ISSN: 1999-4923) is proud to announce its role as a sponsor for the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology conference. This sponsorship highlights the journal’s commitment to supporting the scholarly community and engaging in critical industry discussions with the public.

The 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology will be held in Prague, Czech Republic in 2026. The entire spectrum of topics ranging from engineering aspects of the manufacturing process, the portfolio of commercially available excipients enabling formulation of a large variety of medicinal products, the underlying physico-chemical principles and cutting-edge characterization techniques, to potential pitfalls and hurdles to be overcome during product development, manufacturing and characterization will be addressed.

The conference will be held from 23 to 26 March 2026, from Monday (noon) to Thursday (evening). From Tuesday to Thursday, 4 parallel sessions with oral presentations will be held:

  • 2 sessions on industry-related topics, presented by distinguished invited speakers, giving overviews on the current state of the art in their respective fields;
  • 2 sessions with short talks selected from submitted abstracts, presenting the latest research findings in the broad field of Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

During the entire conference, the accompanying exhibition ResearchPharm® provides a cross-disciplinary platform for pharmaceutical scientists working in all fields of drug development in industry, academia and regulatory bodies. This exhibition is steadily growing and offers the possibility to present and learn about the newest trends and products in the area of pharmaceutical ingredients, developing and processing equipment, analytical technologies, medicinal products, medical devices and contract manufacturing.

In addition, young and experienced scientists from academia and industry will present their latest research achievements in the form of poster presentations, allowing for fruitful scientific exchanges with the authors.

We look forward to seeing you at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

For more information, you may refer to the following website: https://worldmeeting.org/.

20 February 2026
MDPI Virtual Academic Publishing Workshop (New Harvest), 25 February 2026


This Academic Publishing Workshop will be led by MDPI Regional Journal Relations Specialist, Dr. Sally Wu, on “Author Training”. Participants will receive practical advice on essential aspects of writing academic articles. Participants will leave with a clearer understanding of the academic publishing landscape and how to successfully contribute to it.

Date: 25 February 2026
Time: 11:30 a.m.–1:30 p.m. EST

Schedule:

Speaker

Program

Time in EST

Dr. Sally Wu

Introduction

11:30–11:40 a.m.

Dr. Sally Wu

Tips for Writing Great Research Papers

  • Structuring a research paper
  • Tips for every section of a research paper
  • Q&A Session

11:40 a.m.–12:15 p.m.

Dr. Sally Wu

How to Respond to Peer Reviewers

  • Peer Review Reports
  • Examples of Response to Reviewers
  • Q&A Session

12:15–12:50 p.m.

Dr. Sally Wu

AI in Publishing: Challenges and Opportunities

  • AI in scientific publishing
  • How to use AI ethically
  • Q&A Session

12:50–13:30 p.m.

Speakers:

Dr. Sally Wu received a PhD in medical science from the University of Toronto in the fall of 2025. She joined MDPI in February 2025 as an Assistant Editor for Cells. She was recently promoted to Regional Journal Relations Specialist position in August. In this role, she works with many journals, liaising with authors, board members, and EiCs. She has attended several conferences across North America, hosted scholar visits, and taken part in other outreach events.

18 February 2026
MDPI’s Open Access Program Reaches 1,000 Institutions Worldwide

MDPI has surpassed the milestone of 1,000 partners within the Institutional Open Access Program (IOAP). The agreements span 59 countries, covering North and South America, Europe, Asia, Africa, and Oceania.

Last year alone, more than 150 new libraries and academic institutions joined MDPI’s IOAP. With the expansion of an existing consortium deal in Sweden we welcomed a further 75 partners to the program in January 2026, enabling us to surpass the 1,000-partners milestone.

The IOAP supports affiliated researchers by streamlining submission processes, reducing administrative burdens, and offering discounted Article Processing Charges (APCs). Through IOAP membership, more than 61,300 research articles received APC discounts in 2025, driving greater visibility and accessibility for partner institutions and global research communities alike.

"This milestone marks a significant step towards expanding MDPI’s global impact," said Stefan Tochev, MDPI's CEO. "Reaching 1,000 IOAP partnerships is a true testament to the growing trust and collaboration we’ve built with universities, libraries, and research organizations worldwide. We are proud to lead the way in Open Access publishing, ensuring researchers have the support they need to reach global audiences." "The success of our program is reflected in the growing global demand for Open Science and quality publishing services," said Becky Castellon, MDPI institutional partnerships manager. "Equally, institutions are increasingly seeking Open Access publishing options that support funder and national mandates. Joining the IOAP makes compliance simple."

11 February 2026
MDPI Webinar | World Cancer Day, 12 February 2026


To commemorate World Cancer Day 2026, MDPI is delighted to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique,” this series reminds us that each story, discovery, and voice plays a vital role in strengthening the world’s collective fight against cancer.

Kicking off with our February session, this first installment welcomes leading voices in oncology to share impactful insights, raise awareness, and spotlight breakthrough research.

Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts in cancer prevention, diagnosis, and treatment.

Together, we will honor every patient’s journey, elevate the contributions of researchers, and reinforce the power of collective action in the fight against cancer.

Date: 12 February 2026
Time: 6:00 p.m. CET | 12:00 p.m. EST | 1:00 a.m. CST (Asia)
Webinar ID: 899 8080 6135
Webinar Secretariat: journal.webinar@mdpi.com

Register now for free!

Program:

Speaker and Presentation Title Time in CET Time in EST
Introduction 6:00–6:10 p.m. 12:00–12:10 p.m.
Dr. Xiang Xue
PINK1 Deficiency Facilitates Mitochondrial Iron Accumulation and Colon Tumorigenesis
6:10–6:30 p.m. 12:10–12:30 p.m.
Dr. Federico Pio Fabrizio
Epigenetics of KEAP1/NRF2 Signaling: From Molecular Mechanisms to Clinical Implications
6:30–6:50 p.m. 12:30–12:50 p.m.
Dr. Anis Ahmad
Protecting Healthy Organs While Treating Cancer: New Molecular Strategies to Improve Survivorship
6:50–7:10 p.m. 12:50–1:10 p.m.
Dr. Hiroaki Kiyokawa
Stabilizing Tumor Suppressors: Therapeutic Frontiers in Precision Medicine
7:10–7:30 p.m. 1:10–1:30 p.m.
Q&A Session 7:30–7:55 p.m. 1:30–1:55 p.m.
Closing of Webinar 7:55–8:00 p.m. 1:55–2:00 p.m.

After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.

Webinar Keynote Speakers:

  • Dr. Xiang Xue, Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico, USA;
  • Dr. Federico Pio Fabrizio, Department of Medicine and Surgery, Faculty of Medicine, Kore University of Enna, Italy;
  • Dr. Anis Ahmad, Department of Radiation Oncology, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, USA;
  • Dr. Hiroaki Kiyokawa, Department of Pharmacology, Feinberg School of Medicine, Northwestern University, USA.

6 February 2026
Interview with Dr. Zizhao Xu—Winner of the Pharmaceutics Travel Award


Dr. Zizhao Xu is currently a post-doctoral researcher at Northeastern University, USA, where his research focuses on formulation development and predictive performance evaluation across multiple delivery technologies and modalities, with a particular emphasis on locally acting drug products and nanomedicines. We would like to congratulate Dr. Zizhao Xu on winning the Pharmaceutics 2026 Travel Award.

The following is an interview with Dr. Xu:

1. As the winner of this award, what would you most like to express?
I am deeply grateful to Pharmaceutics for this recognition. This award is both an honor and an encouragement, and it reinforces my commitment to advancing pharmaceutical sciences through impactful, translational research.

2. How did you first become aware of this award, and what inspired you to submit your application?
I learned about the travel award through Pharmaceutics announcements and my PI’s recommendation, and felt it aligned well with my research goals. The opportunity to present my work, engage with the scientific community, and gain feedback from experts motivated me to apply.

3. Could you briefly introduce your primary research focus and share an update on your current progress? Looking ahead, what do you anticipate will be the key emerging topics in your field over the next few years?
My research focuses on formulation development and predictive performance evaluation across multiple delivery technologies and modalities, with a particular emphasis on locally acting drug products and nanomedicines. My current research focuses on developing in vitro–based characterization strategies to support the evaluation and approval of generic drug products, thereby advancing regulatory science. Ultimately, this work aims to improve public access to high-quality, safe, and affordable topical rectal and vaginal medications.

4. What significance does this award hold for your research career and your participation in this conference?
This award provides invaluable support for attending the conference and presenting my work to a broader audience. It also serves as strong recognition of my research efforts and helps me build meaningful connections with researchers and industry professionals.

5. In your view, how can academic journals and publishers further support early career researchers and the broader academic community?
Academic journals and publishers can play a meaningful role in supporting early career researchers by lowering barriers to participation in the scholarly community. For example, travel awards and publication fee waivers can make it easier for trainees and junior investigators to share their work at conferences and in high-quality journals, which is critical for career development. In addition, guided peer-review opportunities would be valuable in helping junior scientists develop critical skills in scientific evaluation and scholarly communication. Expanding these initiatives would not only benefit individual researchers but also strengthen the rigor, diversity, and sustainability of the scientific community as a whole.

6. Based on your experience, do you have any specific suggestions for the continued development of Pharmaceutics?
Pharmaceutics could further strengthen its impact by expanding Special Issues focused on emerging technologies, encouraging more interdisciplinary research, and sustaining initiatives such as awards to scientists across different career stages, with particular support for early career investigators, as well as creating avenues for editorial engagement that broaden participation in the journal’s scholarly community.

6 February 2026
Interview with Dr. Giuseppe Francesco Racaniello—Winner of the Pharmaceutics Travel Award


Dr. Giuseppe Francesco Racaniello is currently a post-doctoral researcher at the University of Bari Aldo Moro, Italy, where his research focuses on advanced drug delivery systems, with particular emphasis on 3D printing technologies for personalized medicines. We would like to congratulate Dr. Giuseppe Francesco Racaniello on winning the Pharmaceutics 2026 Travel Award.

The following is an interview with Dr. Racaniello:

1. As the winner of this award, what would you most like to express?
First of all, I would like to express my sincere gratitude to the Pharmaceutics Editorial Board and the Award Committee for this recognition. Receiving this award is both an honor and a strong motivation to continue pursuing high-quality research in pharmaceutical technology. I see it as a recognition not only of my individual work but also of the collaborative efforts of my research group, PhartecoLab, whose support has been fundamental to my scientific development.

2. How did you first become aware of this award, and what inspired you to submit your application?
I became aware of the Pharmaceutics Travel Award through the email communications sent by the journal. What inspired me to apply was the opportunity to showcase my research in the field of pharmaceutical 3D printing and advanced manufacturing technologies. In particular, the fact that this award is specifically designed to support early-career researchers who wish to present and disseminate their work was a strong motivation. I considered it a valuable opportunity to increase the visibility of my research within a highly relevant scientific community.

3. Could you briefly introduce your primary research focus and share an update on your current progress? Looking ahead, what do you anticipate will be the key emerging topics in your field over the next few years?
My primary research focus is on advanced drug delivery systems, with particular emphasis on 3D printing technologies for personalized medicines, including direct powder extrusion and pressure-assisted manufacturing. I work on the development of patient-tailored dosage forms such as orodispersible films, solid oral dosage forms, and wound-healing platforms, often integrating polymer science, solid-state characterization, and biopharmaceutical evaluation.
Currently, my work is centered on optimizing formulation design and manufacturing parameters to improve drug release, stability, and patient compliance, especially for thermolabile or poorly soluble compounds. In parallel, I am increasingly focused on the development of personalized pharmaceutical dosage forms that are functionally engineered to be mucoadhesive or site-specific. A significant part of my research also addresses the production of dosage forms for orphan drugs, medicines with limited availability, and pediatric formulations that are currently not available on the pharmaceutical market, with the aim of filling unmet clinical needs through advanced manufacturing technologies.
Looking ahead, I believe that key emerging topics will include personalized and decentralized pharmaceutical manufacturing, the integration of digital health and 3D printing, the use of sustainable and bio-based excipients, and the translation of additive manufacturing technologies into regulated clinical and hospital settings.

4. What significance does this award hold for your research career and your participation in this conference?
This award represents an important milestone in my early research career. It provides tangible support for my participation in the next PBP 2026 conference, facilitating scientific exchange, networking, and discussion with leading experts in the field. Beyond the financial aspect, the award enhances the visibility of my work and reinforces my commitment to pursuing innovative research directions within pharmaceutical sciences.

5. In your view, how can academic journals and publishers further support early career researchers and the broader academic community?
Academic journals and publishers play a crucial role in supporting early career researchers by promoting transparent peer review, offering mentorship-oriented feedback, and providing opportunities for visibility, such as awards, Special Issues, and invited contributions. Initiatives that reduce publication barriers, encourage interdisciplinary research, and support open science practices are also essential to foster innovation and inclusivity within the academic community.

6. Based on your experience, do you have any specific suggestions for the continued development of Pharmaceutics?
Based on my experience, Pharmaceutics could further strengthen its impact by continuing to support cutting-edge topics such as personalized medicine, additive manufacturing, and sustainable pharmaceutical technologies. Expanding thematic Special Issues, enhancing engagement with early career researchers, and promoting high-quality methodological and translational studies would further consolidate the journal’s position as a leading platform in pharmaceutical sciences.

5 February 2026
Acknowledgment to the Reviewers of Pharmaceutics in 2025


The editorial office of Pharmaceutics would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Pharmaceutics received 8868 review reports from contributors across 89 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.

The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Pharmaceutics.

A. Guillermo Bracamonte Hai-Shu Lin Natallia Dubashynskaya
Aamir Ali Khan Haitao Liu Nataša Bubić Pajić
Abdul Sadiq Haizhou Zhu Natassa Pippa
Abdurraouf Mokhtar Mahmoud Hakim Faraji Nesrine El Gohary
Abhishek Gupta Hamzeh Kiyani Nicola Alberto Valente
Abraham Oluwole Han Xu Nicole L. Snyder
Abu Bakar Siddique Hanna Harant Nicoleta Todoran
Achraf Ghorbal Hans Bäumler Nihal Elsayyad
Ádám Juhász Hao Li Nihal Sarier
Adawiya Haider Hao-Han Pang Nikita A. Kuznetsov
Adeel Sattar Haoyu Wang  Nikita Vasilev
Adrian Bogdan Țigu Harpreet Kaur Niko Radulović
Adriana Elena Bulboacă Hassan Almoazen Nikolaos Bikiaris
Agnes Farkas Hassan Maleki Nikolaos Bouropoulos
Agnieszka Rusak Hassan Rasouli Nikolay Polyakov
Agnieszka Szewczyk Hayat Ullah Nikolay Sergeevich Zimnitskiy
Agnishwar Girigoswami Hayder Adnan Fawzi Nikolett Kállai-Szabó
Agustina Alaimo He Yin Nilakshi Barua
Ahmed El-Fiqi Hector Katifelis Ning Wang
Ahmed G. Hegazi Hemanth Kumar Mamidi Nizar Al-Zoubi
Ahmed M. Agiba Hend Abdel Bar Noha M. Badawi
Ahmed M. Mostafa Henrike Lucas Noha Swilam
Aida A. Abd El-Wahed Heru Agung Saputra Norma Serrano-Garcia
Aimin Jiang Hicham Wahnou Norrie Pearce
Aisha Mofeed Abdelhady Ahmed Himanshu Paliwal Nour E.A. Abd El-Sattar 
Ajay Singh Hinojal Zazo Octavio Galindo-Hernandez
Ajaz Ahmad Dar  Hirokazu Okamoto Oisín Kavanagh
Akinori Kuzuya Hitesh Chopra Olaf Gefeller
Akshaya Tatke Ho Wan Chan Oleh Koshovyi
Ala' Salem Hong Zhou Olga Goryacheva
Alaa Kareem Niamah Hongyuhang Ni Olga Iakobson
Alap Ali Zahid Hossam Samir El-Sawy Olga Ivanovna Vernaya
Alberto Minassi Houman Alimoradi Olga Kartina
Alberto Ospina Stella Houssem Boulebd  Olga Luzina
Albina Ziganshina Hristina Zlatanova-Tenisheva Olga M. Tsivileva
Aldo Amaro-Reyes  Hui Xu Olga Mostovaya
Alejandro J. Alvarez Hui-Qi Qu Olga N. Pozharitskaya
Aleksander Mendyk Hussein Mohammed Eid Olga Protchenko
Aleksandra Kaczorowska Ibrahim Al Nasr Olga Redina
Aleksandra Pavićević Ibrahim Tantawy Olga S. Zueva
Aleksandra Radosavljević Iglika Lessigiarska Olivera Marković
Aleksandra Viktorovna Sitenkova Igor A. Dyachenko Ossama Mohamed Sayed
Alemtsehay Tesfay Reda Igor B. Sivaev Ovidiu-Cristian Oprea
Alessandra Rossi Igor Belenichev Ozgur Esim
Alessandro Tubita Igor Dmitrievich Zlotnikov Pablo Eduardo Cardoso-Avila
Alevtina Grishanova Igor L. Fufurin Padmanabhan Mahadevan
Alexander A. Gusev Igor Mezhevoi Parastoo Pourali
Alexander Lomzov Ilaria Ottonelli Parthiban Chokkalingam
Alexander M. Demin Ilfir Ramazanov Parvin Zamani
Alexander Olegovich Chizhov Ilkay Erdogan Orhan Pascal Bonnet 
Alexander Simenel Ilya Khodov Pathum Chandika
Alexandra Cristina Tocai-Moţoc Ilya V. Ozhogin Patrícia C. Pires
Alexandra Pusta Iman Alfagih Patrick Martin
Alexey Chubarov Ioana-Mirela Vasincu Patrycja Kleczkowska
Alexey Churov Ioanna-Katerina Aggeli Paula Wróblewska-Łuczka
Alexey Feofanov Iogann Tolbatov Paulo Cesar De Morais
Alexey G. Mittenberg Ionut-Iulian Lungu Pavel Makarevich
Alexey V. Ermakov Irina A. Tarasova Pavel Padnya
Alexi Kiss Irina M. Le-Deygen Pavel Ryšánek
Alexis Oliva Iryna Soltys Pavel Zelenikhin
Alfio Battiato Isaac Yves Lopes Macêdo Paweł K. Kunicki
Ali Al-samydai Ishwor Pathak Payal Ganguly
Alicia Ponte-Sucre Ismail Ismail Pedro Brandão
Alicia Rodríguez-Gascón Israa Radwan Pedro Velho
Alicja Stachelska-Wierzchowska Israel González-Méndez Per Sjogren
Allan Patrick Macabeo  István Baczkó Peter Timmins
Amal A. Elkholy Itamar Luís Gonçalves Peter V. Dubovskii
Amarinder Singh Iulia-Ioana Stanescu-Spinu Philippe-Henri Secrétan
Amarjitsing Rajput Ivan Stoikov Pilar López Cornejo
Amin Orash Mahmoudsalehi Ivan V. Semenyuta Pilar Pérez-Lozano
Amir Jafari Ivana Institute Guševac Stojanović Piotr Dobrzynski
Amira Soliman Ivaylo Dimitrov Piotr M. Zieliński
Amit Kumar Nayak Ivelina Tsacheva Podma Pollov Sarmah
Amit Singh Yadav Iwona Maria Golonka Polina Alekseeva
Amiya Kumar Patra J. P. Jose Merlin Poonam Parashar
Amol Dilip Gholap J.M Flórez-Castillo Popat Mohite
Ana Brankovic Jacqueline Johnson Prabhanjan Giram
Ana Iglesias-Mejuto Jaime Conceição Prabu Kumar Seetharaman
Ana Isabel Fernandes Jamal Rafique Pradeep Kumar
Ana Paula dos Santos Matos James B. Fink Pradeep Kumar Jaiswal
Ana Pilipovic Jamir Pitton Rissardo Pradeepraj Durairaj
Ana R. Costa Janaína Oliveira Gonçalves Prashant Singh
Ana Reis-Mendes Jatinder Singh Prasopchai Patrojanasophon
Ana Rita Jesus Javier Lopez Pratap Basim
Anam Ahsan Javier Mauricio Anaya Mancipe Pratchaya Tipduangta
Anastasia V. Shishkina Jayanta Kumar Patra Pravin Hivare
Anastasiya Solovieva Jelena Bašić Preeti Kush
Andre J. Van Wijnen Jelena Radovanović Prem Singh
Andreas Tsakalof Jelena Spasojevic Pritha Bose
Andreea-Veronica Dediu Botezatu Jennifer Walsh Przemysław Dorożyński
Andrei Khlebnikov Jerzy Tadeusz Chudek Pui Shan Chow
Andrei Okhokhonin Jia-Ling Ruan Qi Cui
Andrew Stoker Jianjun Cheng Qiang Jiang
Andrey Elchaninov JianLi Gao Qin Xiang Ng
Andrey Kuskov Jianli Tao  Qingfeng He
Andrey Minakov Jianzhong Wang Quanying Bao
Andrey Zamyatnin Jiaquan Yu Radosław Balwierz
Andrey Zhdanov Ji-Hoon Na Rafael Catarino Castro
Andrzej Parzonko Jihui Tang Rafael Herrera-Bucio
Angel Guillermo Bracamonte Jing Liu Rafael Moreno-Gómez-Toledano
Angel Josabad Alonso-Castro Jing Zhang Raffaele Longo
Angelica Sharapova Jinnipha Pajoubpong Rahul Maheshwari
Angeliki Siamidi Jinrun Liu Rahul Tiwari
Anica Petrovic Jinsong Tao Rai Campos Silva
Anil Bidkar Jinyang Li Rais Pavlov
Anilkumar Thaghalli Shivanna Jinyu Guo Rajamani Ranjithkumar
Aninidta De Joanna Kołodziejczyk-Czepas Rajendra Awasthi
Anirban Das Joanna Sobiak Raju Senthil Kumar
Anisha D’souza João Basso Ramkumar Kunka Mohanram
Anita Bogdanov Joaquim Suñer-Carbó Ramya Tokala
Anna Alekseevna Skuredina Joe M. Viljoen Rania Hathout
Anna Gumieniczek John Joseph O'Connell Rasha M. Elkanayati
Anna Kovalenko Jomarien García-Couce Ravi Kumar Nagiri
Anna Rita Bilia Jonathan R. Roth Ravi Maharjan
Anna Soloveva José A. Saéz Cases Ravi Varala
Annalisa D'Arco José Araújo-Neto Ravichandran Kollarigowda
Annarita Falanga José Luis Olivares-Romero Ravis Zalubovskis
Anne Yagolovich Jose M. M. V. Sousa Raviteja Bulusu
Anton Kiselev José Manuel Benito Reetesh Kumar
Anton Tkachenko Jose Tudela Rehab Abdelmonem
Antonello Barresi Josipa Bukic Renae L. Wilson
António Jorge Guiomar Jovanny A. Gómez Castaño  Renata Maria Varut
Anupam Anand Ojha Jozsef Dudas Renata Mikstacka
Aparna Shukla Ju Hee Kim Renato Sonchini Gonçalves
Aránzazu Zarzuelo Castañeda Juan Luis Chávez Pacheco Reza Bazargan-Lari
Archana Krovi Juan Manuel Guzman-Flores Richard John Bruce Francis
Arif Mermer Juan Manuel Lázaro-Martínez Richard Perosa Fernandes
Artem D. Rogachev Juan Niclós-Gutiérrez Rita Oliveira
Artur A. Khannanov Judith Mihály Ritam Das
Arun Kumar  Juncan Anca Maria Riyaz Ali M. Osmani
Ashish Kumar Agrawal Junhuang Jiang Robert-Alexandru Vlad
Ashraf Mohammed Junichi Sawada Robin Haunschild
Ashraf N. Abdalla Junmei Zhang Rofida Albash
Askar K. Gatiatulin Junqiang Ding Rohit Kumar
Ataf Ali Altaf Jun-Sheng Zhang Roman P. Terekhov
Atheer Zgair Junzi Wu Rongjin Sun
Athina Angelopoulou Jurij Trontelj Rongqin Huang
Atiya Fatima Kah Hui Wong Rosa María Oliart-Ros
Atsushi Kambayashi Kamil Gareev Rosaria Schettini
Atul Garkal Kamila Korzekwa Rosemary Stanton
Avinash Mishra Kamyar Khoshnevisan Roshan Katekar
Ayelén Amelia Hugo Kannan Badri Narayanan Roya Binaymotlagh
Ayhan Celik  Kant Sangpairoj Ruchi Singh
Ayyappasamy Sudalaiyadum Perumal Karel Allegaert Saba Zia
Azadeh Akhavan Taheri Borojeni Karim Osouli Bostanabad Sagar B. Dhoble
Azucena Ibeth Carballo Villalobos Karthika Muthuramalingam Sagar Narala
Azza SalahEldin El-Demerdash Kasandra Bélanger Sagar Ramlal Pardeshi
B.H. Jaswanth Gowda Katarina Vučićević Sagar Salave
Bahgat Fayed Katarzyna Roszek Sajid Asghar
Baiju Pazhamkalathil Krishnan Katarzyna Sosnowska Sajjad Ahmad
Bai-yan Li Katarzyna Wilpiszewska Salman Afroze Azmi Mohammed
Baljinder Singh Kawtar Fikri-Benbrahim Samanta da Silva Gündel 
Balraj Gopula Ke Liu Samet Özdemir
Balzhima Shagdarova Keisuke Fukunaga Sammar F. Elhabal
Banlanjo Umaru Kevinn Eddy Samson Aisida
Bappaditya Naskar Khaled AboulFotouh Samy Emara
Barbara Sanchez-Dengra Khalid Mohammad Sandeep Kumar Mishra
Beatrice Severino Khmais Zdiri Sandra Aulia Mardikasari
Belmiro Pereira Duarte Khushboo Singh Sanela Savic
Benjamin A. Kuzma  Ki Young Huh Sanjiv Prashar
Bharath Kumar Villuri Kirsten J. M. Schimmel Santanu Ghosh
Bhasker Radaram Kirubakaran Palani Sara Baldassari
Bhupendra G. Prajapati Kohei Homma Sara Meirinho
Bhupinder Kumar Konstantin Rodygin Sarah Thomas
Bidyut Saha Koyeli Girigoswami Sarfaraz Hashemkhani Zolfani
Bijay P. Chhetri Koyo Nishida Saroj Basak
Bilel Hadrich Kozhunova Elena Sateesh Dubbu
Birutė Grybaitė Krishna Kishore Mahalingan Sateesh Kumar Vemula
Biswajit Basu Krishna Yadav Satish Rojekar
Brian Reed Krist V. Gernaey Satoshi Takei
Bruno Pagano Kunal Pal Saúl Navarro-Marchal
Caio Haddad Franco Kunal Ranjan Sauradip Chaudhuri
Candan Perry Hizel Kyeong Soo Kim Sawsan Zaitone
Carina Félix Kyriakos Kachrimanis Sayan Das
Carlos Alberto Calderon-Ospina Laichang Zhang Scott Canfield
Carlos Cuevas-Suárez Lakshmanan Govindan Seeprarani Rath
Carlos Lodeiro Lalit Kumar Selestin Raja Iruthaya Pandi
Carlos Monteiro László Hazai Semra Ince 
Castro William Lauren Nicole Ruger Senthil Kumar K.J.
Catarina Pereira-Leite Laxman Subedi Sergei Grishin
Caterina Arcangeli Laxmi Swetha Karanam Sergei L. Shmakov
Cécil J. W. Meulenberg Leijiane Figueira de Sousa Sergey Moskvin
Chae Bin Lee Leila Arabi Sergey O. Ilyin
Chalet Tan Leonard Ionut Atanase Sergey Sedykh
Charlotte Preston Leyla Ovchinnikova Sergio Alberto Bernal Chávez
Chen Meng Li Li  Serhii Varvarenko
Chen Xie Li Zhang Seung-Hyun Jeong
Cheol Moon Liang Zheng Sevim Köse
Chiara Da Pieve Lidia Ashrafovna Baltina Seyed Mohammad Mahdi Dadfar
Chinedu Ogbonnia Egwu Lídia Gonçalves Shah Faisal
Choon Fu Goh Liming Chen Shahla Mirzaeei
Chou-Yi Hsu Ling Ding Shakti Nagpal
Christian Chapa Lingaiah Maram Shao-Bin He
Christian Wiraja Lionel F. Gamarra Sharif MD Abuzar
Christie Ying Kei Lung Liza Józsa Shehwaz Anwar
Christina Voycheva Ljilja Torovic Sherien M. El-Daly
Christine Dufès Longbing Ling Shiji Zhao
Chun Kit K. Choi  Lu Gaohua Shikai Jin
Chuwen Li Lu Tang Shile Huang
Cláudia Sofia Mestre Viegas Luana Mota Ferreira Shintaro Fumoto
Clemens Leo Gögele Luca Liviu Rus Shinu Pottathil
Cordula Stillhart Lucia Maria Rus Shoko Itakura
Cornelia Mircea Lucia Pirvu Shuai Ren
Cristina Mihaela Ghiciuc Luis Apaza Ticona Shuangqing Wang
Cristina Velasquillo Luis Enrique Cobos Puc Shuiyu Lu
Cristina Vocca Luis Exequiel Ibarra Shunsuke Kiuchi
Cyril Fersing Luis G. Sequeda-Castañeda Shyam Kumar Gudey
Daisuke Inoue Lukasz Dobrek Sıdıka Genç
Dalia S. Ashour Łukasz Szeleszczuk Silvana Alfei
Dalila Miele Luminita Confederat Silvestre Bongiovanni Abel
Dang-Khoa Vo M Mustafa Azeem Silvia Tampucci
Danial Khayatan M. Ramesh Simon Bernard Iloki Assanga
Daniel Balleza Maciej Przybyłek Simone Brogi
Daniel Gromadzki Madjid Soltani Sipak Joyasawal
Daniel Yarosh Magdalena Cristina Stanciu Sita Aggarwal
Daniela Culita Magdalena Paczkowska-Walendowska Siu Hong Dexter Wong
Daniele Vergara Mahendra Singh Sivacharan Kollipara
Daniil Bazanov Mahfuz Elmastas sivaram munnangi
Danijela Horvatek Tomic Mahipal Reddy Donthi Siyamak Safapour
Danijela Petrovic Mahmoud M. A. Elsayed Elsayed Slavomira Doktorovova
Danyi Lu Mahmoud M. Omar Sonia L.C. Pinho
Daria Chudakova Maj Schneider Thomsen Sónia N. Pedro
Darren Bentley Majid M. Al-Sawahli Sophia D. Sakka
Darshan T.G. Maksim A. Burkin Soraia Pinto
David Leavesley  Malcolm Scott Duthie Soubhagya Tripathy
David Sánchez-García Malgorzata Burek Sourabh Mehta
Dawid Siodłak Małgorzata Geszke-Moritz Spyridon Mourtas
Debabrata Mandal Małgorzata Jeleń Srivatsan Ramesh
Débora Luana Ribeiro Pessoa Malleswara Rao Peram Stanislav I. Pekov
Debora Santonocito Mamunur Rashid Stefania Abbruzzetti
Decha Pinkaew Mana Mohan Mukherjee Stefania Dello Iacono
Dejin Zheng Manikanta Murahari Stefanie Dichtl-Zweimüller
Dejun Ma Manuel Cordoba-Diaz Stefano Castellani
Delly Ramadon Manuel-José Lis Arias  Stefano Cicchi
Denis Buxton Marcelino Montiel-Herrera Stefano Fais
Denis Rychkov Marcella Bini Stephanie E. Barrett
Dennis Goulet Marcia Bastos Convento Stephen Richard Tomlin
Denny Satria Marek Wesolowski Stoyanka Atanasova Nikolova
Deokho Lee Margaret Gradova Subhadeep Das
Devesh U. Kapoor Margarita Goldberg Subramanian Natesan
Dezhi Yang Margarita Neganova Sujeet Kumar
Dhanalekshmi Unnikrishnan Meenakshi Margaritis Tsifintaris Suman Basak
Dhanashree Hemant Surve Maria Antonietta Grignano Sung-Min Kang
Dhiraj D. Bhatia Maria Camilla Bergonzi Sunil V Gaikwad
Diana V. Manukovskaya Maria Gemma Nasoni Suprit Dilip Saoji
Diego Romano Perinelli María J. Ortega Surajkumar Fanse
Dignesh Khunt Maria Lepore Sureshbabu Ram Kumar Pandian
Dinesh Kumar Srinivasan Maria Lujan Ferreira Susanne Page
Dinesh Nyavanandi Maria Manuela Gaspar Svetlana Saikova
Dipak Kumar Poria Maria Pakharukova Swati Dahariya
Dmitry Gruzdev Maria S. Lavlinskaya Syed Ali Raza Naqvi
Dmitry Pelageev María Victoria Miranda Syed Haroon Khalid
Dmitry Verbenko Maria Wallert Syed Mahmood
Doaa Alshora Mariadoss Arokia Vijaya Anand Syed Nasir Abbas Bukhari
Dolores Remedios Serrano  Marija Gizdavic-Nikolaidis Szczepan Zapotoczny
Don Green Marilena Vlachou T.M Sridhar
Donato Cosco Marimuthu Govindarajan  Tae Sup Lee 
Dong Kee Yi Marin Simeonov Takaaki Mizuguchi
Dongyang Zhang Marina Holyavka Takanori So
Dorota Chełminiak-Dudkiewicz Mario Jug Tamás Sovány
Dorota Formanowicz Marios Spanakis Tanja V. Soldatovic
Durairaj Siva Marisabel Mecca Tanya Ivanova Topouzova-Hristova
Duran Bao Marko Bašković Tao Sun
Dušan Dimić Marko Z. Krstić Taral R. Lunavat
Dwaipayan Mukherjee Marta Ogorzałek Tarek Mohamed
Dzmitry G. Shcharbin Marta Slavkova Tatiana V. Vygodina
Eduardo Maffud Cilli Marta Szekalska Tatiana Vadimovna Pleteneva
Egor Musin  Martin Schmidt Tatyana Volkova
Egor Olegovich Osidak Martin Walther Teresa M.R. Maria
Egor Plotnikov Martin Ward Thawatchai Phaechamud
Egor Verbitskiy Marvin Xavierselvan Thi Sinh Vo
Ehab Elzayat Masood Khan Thomas Dandekar
Ehsan Vafa Mateusz Kurek Thomas Van Groen
Ekaterina I. Khamzina Mathilde Champeau Tianyuan Zhang
Ekaterina Kolesova Matteo Pavan Tifeng Jiao
Ekaterina Lengert Matthias Nees Tigran Vartanyan
Ekaterina Minskaia Mauricio A. García Tijana Kovačević
Ekaterina Naumenko Mauricio Andres Filippa Timothy R Keiffer
Ekaterina Vladimirovna Silina Maxim Alexeevich Filatov Ting-Yu Lu
Eldrin Arguelles Maxim Arsenyev Todor Trey Koev
Elena A. Pudova Mayank Sharma Tofeeq Ur-Rehman
Elena Dinte Md Bashir Uddin Tomasz Poplawski
Elena Enachi Md Mofasserul Alam Tommaso Felicetti
Elena Tosca Md. Sanower Hossain Tomoya Hikita
Elena V. Tchetina Meera Moydeen  Trevor Norman
Elena V. Uspenskaya Meha Kabra Trong-Nghia Le
Elham Saberian Mehdi Sanati Tudor Sorin Pop
Elide Zingale Mehmet Akyüz Umesh Prasad
Elsa Ching Chan Mehran of Miroliaei Umme Laila Urmi
El-Sayed Hemdan Eissa Melgardt De Villiers Unnati Patel 
Elvira Rozhina Meliha Ekinci Vadim Boyarskiy
Emanuela Barletta Mengfan Li Valentina Krut'ko
Emilio Bucio Menglei Xu Valentina Mittova
Emma Adriana Ozon Menna M. Abdellatif Valentyn Mohylyuk
Emmanuele Parisi Merve Karpuz Valeri Velev
Emoke Pall Michael Gray Valeria Timganova
Enas Eltamany Michael Juhnke Valvanera Vozmediano
Enoch Mensah Michael Kenneth Lawson Van-An Duong
Enrica Chiesa Michał Zarobkiewicz Vance Nielsen
Enrico Gallo Michele Georges Issa Vanessa Bergamin Boralli Marques
Enrico Rosa Mick Welling Vanja Milija Tadić
Eric Nahum Jimenez-Vazquez Miguel Ángel Cabrera-Pérez Vasanthan Ravichandran 
Ernest Meštrović Miguel Angel Puertas-Mejía Vasily A. Aleshin
Ernst Wagner Miguel García-Castro Vasudeva Reddy Netala
Esra Demir Unal Miha Homar Venkatesh Bhumireddy Chinnachennaiahgari
Eugene V. Radchenko Mihaela Carmen Eremia Veronica Soloveva
Eugenia Romano Mihaela Ileana Ionescu Vibhav Gautam
Eugenio Goncalves de Araujo Mihaela Violeta Ghica Victoria Shipunova
Evgenia Korzhikova-Vlakh Mihalj Poŝa Viktor Revin
Evgenia Mitsou Mikhail Gavrilenko Vipul D. Prajapati
Evgeniya Prazdnova Mikhail Rayev Viswas Raja Solomon
Fabián Cuétara-Guadarrama Mikhail S. Drenichev Vitaliy Borisov
Fabio Pastorino Mikko O. Laukkanen Vivek Kumar
Fabrizia Sepe Miléna Lengyel Vlad T. Popa
Fahad Almughem Miloš Kojić Vladimir Ivanov
Faisal Al-Akayleh Mingqing Chen Vladimir Korshun
Fan Yang Minjia Wang Vladimir Malinin
Faraat Ali Min-Soo Kim Vladimir Sergeyev
Farbod Tabesh Mirjana Stupnisek Vladimir Tikhonov
Fares Hezam Al-Ostoot Miryam Perrucci Vladislav Semak
Fatemeh Mortazavi Moghadam Mithun Sarker Vladislav V. Fomenko
Faten Ibrahim Mizanur Rahman Vrinda Gote
Fatih Tok Mladena Lalic-Popovic Waad Hussein Abuwatfa
Fedor Grigoriev Mohamed A. Hassan Waiting Tai
Fei Fan Mohamed Abdelrahim Waleska Dornas
Fei Han Mohamed Al-Fatimi Weichang Li
Felipe Varum Mohamed Attia Weikang Hu
Fernando Javier Barreyro Mohamed Eid Wen Harold Chen
Flavia Zacconi Mohamed F. Zayed Wen Shi
Fleming Martinez Mohamed Gamal Mohamed Wentao Kong
Florentina Geanina Lupascu Mohamed Ibrahim Wing Shing Ho
Franc Vrečer Mohamed M. Badran Xianxiang Xu
Francesca Persano Mohamed Rahamathulla Xin Li
Francisco Dionisio Mohamed S. Kishta Sobhy Kishta Xingbin Yin
Francisco Javier Olivas-Aguirre Mohamed S.A. Darwish Xiuli Li
Gabriel Davi Marena Mohamed Skiba Xuechun Wang
Gabriela Egly Feresin Mohamed Taha Yassin Xue-ming Zhang
Gabriela Pastuch-Gawolek Mohammad A. Alfhili Yahia Z. Hamada
Gaia Dellepiane Mohammad Akrami Yan Kazakov
Galina M. Aleshina Mohammad Arafat Yannis Dotsikas
Gamaleldin Harisa Mohammad Ashfaq Yao Jiang
Ganeshkumar Arumugam Mohammad Fouad Bayan Yedi Herdiana
Gang Li Mohammad Naderan Yeuan Ting Lee
Gareth R. Williams Mohammad Yaseen Abbasi Yi Han
Gaurav Pandey Mohammed Gamal Yi Wang
Gayathri Thevi Selvarajah  Mohammed M. Mehanna Yibo Li
Geanina Voicu Mohd Sajjad Ahmad Khan Yifan Ma 
Geetha Satya Sainaga Jyothi Vaskuri Mohsen Shahrousvand Yijun Mei
Gema Martínez Navarrete Mojhdeh Baghbanbashi Yishen Zhu
Gennadi Saiko Mona M. A. Abdel-Mottaleb Yohei Miyamoto
George A. Gamov Mónica Benito Yong Ai
George Thyphronitis Monica Stamate Cretan Yong Chen
Georgios Pampalakis  Mónika Megyesi Yongjun Li
Giada Botti Monika Śmiga-Matuszowicz Yongqiang Li
Gianpaolo Papaccio Montserrat Pujol Yousaf Khan
Giovanna Bruni Moshi Geso Yue Wang
Giovanna Rassu Mthandazo Dube Yu-Fang Shen
Giovanni Ribaudo Muchtaridi Muchtaridi Yukteshwar Baranwal
Giovanni Rolla Muhammad Azam Yuliya V. Zhuikova
Girum Getachew Demissie Muhammad Bilal Sadiq Yung-Kang Shen
Giuseppe Trapani Muhammad Faizan Nazar Yunhao Ma
Gloria Huerta-Angeles Muhammad Idrees Yury A. Skorik
Goran Baranović Muhammad Latif Zaikuan Josh Yu
Gordana Wozniak Knopp Muhammad Nadeem Zaira Kharaeva
Govindan Suresh Kumar Muhammad Tahir Khan Zakia Belhadj
Gowtham H. G. Mulazim Hussain Asim Zeid ALOthman
Gregor P. Jose Muthukumar Serva Peddha Željka Vanić
Guangyan Du Nádia Araci Bou-Chacra Zeljko Prijovic
Guillermina Ferro-Flores Nafisa Gull Zhen Xiao
Guillermo Alberto Keller Naga Veera Srikanth Vallabani Zheng Yuan
Gulin Amasya  Nagarjuna Narala Zhengpeng Wan
Guo-Bin Ding Nancy Monroy-Jaramillo Zhengwei Huang
Guowei Deng Naresh Yandrapalli Zhenjun Yang
Guoxing Wan Naser-Aldin Lashgari Zhonglei Wang
Gustavo Braga Natalia Hudz Ziran Li
György Kasza Natália M. de Oliveira Zois Tsinas
Györgyi Műzes Natalia Oddone Zsuzsanna Szabó
Hadel Aboenin Natalia Rosiak Zuoxu Xie
Hadi Baharifar Natalia Wilke

Back to TopTop